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Abstract
Background: Although high throughput technologies for gene profiling are reliable tools, sample/tissue heterogeneity
limits their outcomes when applied to identify molecular markers. Indeed, inter-sample differences in cell composition
contribute to scatter the data, preventing detection of small but relevant changes in gene expression level. To date,
attempts to circumvent this difficulty were based on isolation of the different cell structures constituting biological samples.
As an alternate approach, we developed a tissue compartment analysis (TCA) method to assess the cell composition of
tissue samples, and applied it to standardize data and to identify biomarkers.
Methodology/Principal Findings: TCA is based on the comparison of mRNA expression levels of specific markers of the
different constitutive structures in pure isolated structures, on the one hand, and in the whole sample on the other. TCA
method was here developed with human kidney samples, as an example of highly heterogeneous organ. It was validated by
comparison of the data with those obtained by histo-morphometry. TCA demonstrated the extreme variety of composition
of kidney samples, with abundance of specific structures varying from 5 to 95% of the whole sample. TCA permitted to
accurately standardize gene expression level amongst .100 kidney biopsies, and to identify otherwise imperceptible
molecular disease markers.
Conclusions/Significance: Because TCA does not require specific preparation of sample, it can be applied to all existing
tissue or cDNA libraries or to published data sets, inasmuch specific operational compartments markers are available. In
human, where the small size of tissue samples collected in clinical practice accounts for high structural diversity, TCA is well
suited for the identification of molecular markers of diseases, and the follow up of identified markers in single patients for
diagnosis/prognosis and evaluation of therapy efficiency. In laboratory animals, TCA will interestingly be applied to central
nervous system where tissue heterogeneity is a limiting factor.
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Introduction
A central goal in biomedicine is to identify specific markers for
diagnosis and prognosis of diseases and for evaluating treatment
efficiency. Identification of molecular biomarkers is often based on
differential profiling of gene expression [1,2]. Although powerful
technologies for gene expression analysis, e.g. microarrays and
SAGE [3], are nowadays well systematized and highly reliable, the
overall procedure for differential gene expression profiling still
suffers from several flaws. One seldom solved relates to the very
nature of the biological samples, especially when studying
heterogeneous tissues or organs [4,5]. As a matter of fact, random
sampling of a heterogeneous tissue yields samples with different
cell compositions. Thus, differences in gene expression levels
observed between samples may be accounted for not only by true
changes in gene expression, but also by differences in their cell
composition. This artefact increases data scatter and may prevent
detection of small amplitude changes in gene expression, as those
expected for early biomarkers.
Because the diversity of tissue samples composition is inversely
related to their size, this pitfall could theoretically be circumvented
by analyzing tissue fragments large enough to be representative of
the average composition of the whole tissue. Unfortunately, most
often this is not feasible for human tissues/organs since, for
obvious reasons, tissue biopsies are downsized to the minimum
required for histoimmunopathological analysis. Two types of
human biological material are not subject to this difficulty: the
blood, because fairly large volumes are readily available which
allows separating the different cell populations, and tumors
because they mainly consist of a clonal mass of tissue. This likely
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7779explains that differential gene expression profiling has led to
important achievements in hematology and oncology [6,7],
whereas outcomes remain disappointing in other medical fields.
Laser capture micro-dissection (LCM) can provide pure
preparations of the different structures from heterogeneous organs
or tissues [8–10]. However, LCM remains tedious, especially when
coupled with procedures for high quality RNA extraction, and is
difficult to set up for routine use in clinical laboratories.
Alternately, we developed a tissue compartment analysis (TCA)
method that allows quantifying the fractional volume of the
different structures constituting tissue samples and solving the
problem of tissue sample heterogeneity, and applied it to identify
biomarkers.
Results
Principle of the Method
Calculation of the fractional volumes of the different constitutive
structures of any sample is based on the comparison between
mRNA expression levels of specific markers of the different
constitutive structures in pure isolated structures, on the one hand,
and in the whole sample on the other. The fractional volume of
any structure X (%Vx) is given by:
%VX~
WMx
SMx
P
x
WMx
SMx
|100
where WMx and SMx designates the abundance of a X-specific
transcript marker (Mx), in the whole sample and in the pure
structure X respectively.
This TCA method was applied to human kidney, as an example
of highly heterogeneous tissue, using both normal and pathological
kidney tissue. The analysis was restricted to the four main
structures that constitute human kidney biopsies, i.e. glomeruli (G),
proximal convoluted tubules (PCT), cortical thick ascending limbs
of Henle’s loops (cTAL) and cortical collecting duct (CCD). WMx
was quantified by RT-PCR and, for SMx, we took advantage of
published data from SAGE libraries generated from pure
populations of the different structures constituting human normal
kidney tissue [11] (table 1).
Table 1. Occurrence in glomerular and tubular SAGE libraries from human kidneys of the specific tags of genes analyzed in this
study.
G PCT cTAL CCD Tag sequence
Structure-specific markers
PODXL, Podocalyxin-like (NM_001018111) 129 0 0 0 ATATATGTCT
WT1, Wilms tumor 1 (NM_000378) 18 0 0 0 TTACAAGATA
ALDOB, Aldolase B (NM_000035) 0 307 7 2 AAATTTCACA
SLC13A3, Solute carrier family 13 member 3 (NM_022829) 0 71 0 0 TGGGGTCTGT
SLC12A1, Na/K/2Cl cotransporter 2 (NM_000338) 0 0 149 1 TGAGCAATCA
UMOD, Uromodulin (NM_003361) 3 3 837 4 AATCCCGTGT
AQP2, Aquaporin 2 (NM_000486) 0 1 3 157 ACACACACCA
FXYD4, Corticosteroid hormone induced factor (NM_173160) 0 2 0 191 AGGAGGCTTC
Ubiquitous reference genes
RPLP1, Ribosomal phosphoprotein, large, P1 (NM_001003) 53 49 59 74 AATGCCCTCA
RPL19, Ribosomal protein L19 (NM_000981) 124 98 75 83 AGCCATTAAA
PPIA, Peptidylpropyl isomerase A (NM_021130) 8 12 17 20 ATTTGGTGTG
Genes selected for data standardization
DUSP9, Dual-specificity phosphatase 9 (NM_001395) 0 1 30 0 TATGCTTGTT
GSTA1, Glutathione S-transferase a1 (NM_145740) 1 43 4 0 TGATGTGAAT
KCNJ1, Renal outer-medullary potassium channel (NM_153767) 0 3 27 23 CCCACCTGCA
MUC1, Mucin 1 (NM_002456) 1 2 21 26 CTGAACTGGA
NPHS2, Podocin (NM_014625) 68 0 0 0 CCTCACTGAA
PTGER1, Prostaglandin E receptor 1 (NM_000955) 0 0 0 21 CTGGACCCTT
Pathology biomarkers
SERPINH1, Serpin peptidase inhibitor, H1 (NM_001235) 1 1 0 2 AAGCCTGCCT
COL4A5, Collagen, type IV, alpha-5 (NM_000495) 2 0 0 0 AAGATAACAT
CTGF, Connective tissue growth factor (NM_001901) 239 2 4 5 AGTTTTTTCA
DCN, Decorin (NM_001920) 107 0 0 0 AAGTGACTTC
TRPC6, Transient receptor potential cation channel C6 (NM_004621) 1 0 0 0 AGAAAATACA
Data, from Chabarde `s-Garonne et al [11]. correspond to tag counts normalized to 50,000 total tags per library. Human Genome Organization (HUGO) gene symbol is
followed by a usual name and the RefSeq identification. SAGE data are available at GEO (www.ncbi.nlm.nih.gov/geo/) (GSM10419, GSM10423, GSM10426 and
GSM10428). Tag sequences are also provided.
doi:10.1371/journal.pone.0007779.t001
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To minimize quantification errors, two transcript markers were
utilized for each structure. The four couples of markers were
selected among candidates in human tubule SAGE libraries [11]
based upon the following criteria: 1) they are expressed at high
level to facilitate accurate PCR quantification (table 1); 2) they
encode proteins relevant to specific functions of the different
kidney structures, so that their expression is likely negligible in non
considered kidney structures, and 3) their expression should
display minimal inter-individual differences. Based on these
criteria, we selected podocalyxin-like (PODXL) and Wilms tumor
1 (WT1) for glomerulus, aldolase B (ALDOB) and the solute
carrier SLC13A3 for proximal tubules, the Na/K/2Cl co-
transporter NKCC2 (SLC12A1) and uromodulin (UMOD) for
thick ascending limbs of Henle’s loop, and aquaporin 2 (AQP2)
and CHIF (FXYD4) for CCD. Data from the literature and from
SAGE libraries (Table 1) indicate that these transcripts are specific
markers of the different kidney structures, and results in figure 1
(filled circles) show the correlations existing between the expression
levels determined by RT-PCR of these four pairs of structure-
specific markers in .60 normal kidney samples from different
patients. For PCT, cTAL and CCD markers, a high correlation
(0.66,R
2,0.80) existed between expression levels of the two
markers whereas the correlation was weaker for the glomerulus
markers (R
2=0.38). Importantly, the slope of the regression line
(the ratio of the WM of the two markers) was close to the calculated
ratio of occurrence of the cognate tags in SAGE libraries:
glomerulus, WPODXL/WWT1=9.0, SPODXL/SWT1=7.2; PCT,
WALDOB/WSLC13A3=4.7,S ALDOB/SSLC13A3=4.3;cTAL,W SLC12A1/
WUMOD=0.19, SSLC12A1/SUMOD=0.18; CCD, WAQP2/WFXYD4=
0.89, SAQP2/SFXYD4=0.82. This demonstrates the quantitative
equivalence of SAGE and RT-PCT data. The selected markers
proved to be usable also for pathological tissue (Fig. 1, open
circles) since a high correlation (0.76,R
2,0.92) existed between
expression levels of the two markers for the four structures in .40
pathological kidney samples, and the slope of the regression lines for
normal and pathological samples were not statistically different
(0.1,t,1.3).
Validation of TCA Method
TCA method was validated by comparing the sample composition
calculated as indicated above with that provided by histo-morpho-
metric analysis on serial normal kidney sections adjacent to that used
for RT-PCR quantification of structure markers (Fig. 2A–2C).
Results obtained on 8 LCM-derived tissue pieces from two different
kidneys (Fig. 2D) demonstrated a strong correlation (R
2=0.945)
between the fractional volume of the different kidney compartments
determined byTCA method and by histo-morphometryin all samples
analyzed. In addition, the slope of the regression line was not
statistically different from 1 (t=1.03). This not only confirms the
accuracy of the TCA method, but also that of the underlying pre-
requisite, i.e. the comparability of SAGE and RT-PCR data.
Diversity of Human Kidney Samples
TCA revealed a wide spectrum of representations of the
different structures among .90 normal samples (Fig. 3A) and
Figure 1. Expression of structure-specific markers in human kidney. Relationship between the expression levels of specific markers of
glomerulus (PODXL and WT1), proximal tubule (ALDOB and SLC13A3), cortical thick ascending limb of Henle’s loop (SLC12A1 and UMOD) and CCD
(AQP2 and FXYD4) in .60 normal (closed symbols) and .40 pathological kidney samples (open symbols). For each structure, the slopes of the
regression lines corresponding to normal (full line, equation and R
2 at bottom right) and pathological samples (dotted line, equation and R
2 value at
top left) were not statistically different (t test).
doi:10.1371/journal.pone.0007779.g001
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the fraction constituted by PCTs varies from 1 to .95% of the
whole sample. This diversity is related to tissue sampling rather
than to inter-patient variations since a similar diversity was
observed between twenty fragments from a same kidney (Fig. 3C).
Data Standardization
These marked differences in tissue composition constitute a
major determinant of inter-sample variance in gene expression
level for all genes unevenly expressed in the different structures.
This can be overcome by standardizing data with a gene- and
sample-specific factor (SF) which accounts for both the differential
fractional volume of and gene expression in the various structures
SFg~
X
x
%Vx|Sgx
where Sgx is the abundance of the transcript (g) in the different
compartments (here, the occurrence of the candidate transcript
tag).
When compared to classical data standardization procedure
using RPLP1 as a so-called reference gene[12], standardization
with SF markedly reduced data scatter as the variance was
reduced 1.6–2.0 fold (Fig. 4).
Identification of Pathology Markers
Using immuno-histochemistry or in situ hybridization, i.e.
analytical methods that palliate kidney heterogeneity, authors
reported increased expression of putative markers in several
kidney pathologies [13–17]. We therefore searched whether
standardization of data would allow identification of these markers
by RT-PCR on heterogeneous kidney samples. Results in Fig. 5
show that, conversely to classical standardization procedure,
standardization with SF allowed revealing the over-expression of
such pathological markers.
Localization of Gene Expression
One can take advantage of sample structural diversity to identify
the site of expression of a gene, through selection of subgroups of
samples with different compositions. Using this strategy, we found
that DCN, GSTA1 and DUSP9 were preferentially expressed in
G, PCT and cTAL respectively whereas MUC1 was expressed in
both cTAL and CCD (Fig. 6). These conclusions are consistent
with known expression profiles of these four genes (Table 1).
Discussion
This paper describes a tissue compartment analysis method to
quantify the proportion of the different cellular structures in a
kidney tissue sample, such as a surgical piece of kidney or a renal
biopsy. The method was initially designed and validated using
normal kidney tissue because it is a readily available source of
tissue, and because we disposed of published data regarding the
segmental expression of thousands of genes in such tissue.
However, TCA proved also efficient for analyzing kidney needle
biopsies from patients with a wide variety of kidney diseases.
TCA revealed the extreme diversity of composition of kidney
samples (Fig. 3). Consequently, use of a standardization factor that
eliminates expression variability linked to differential sample
composition and differential gene expression in the various
structures proved to be highly efficient for reducing inter-sample
data scatter (Fig. 4) and, thereby, for identifying pathological
biomarkers (Fig. 5). Of course, the beneficial effect of standard-
ization on data scattering mainly depends on how the considered
gene is expressed in the various structures. For a gene evenly
Figure 2. Validation of TCA by histo-morphometric analysis of kidney tissue composition. A. Overview of three kidney serial sections
stained with anti-uromodulin antibody (I), anti-AQP2 antibody (II), and toluidine blue (III, micrographs after LCM). The zones (1 to 4) used for analysis
are delineated. B. Higher magnification images of zones 4 (before LCM for section III). C. Image analysis of zone 4 allowing the construction of the
color-coded image (G, yellow; PCTs, blue; cTAL, green; CCDs, red; grey, remaining tissue) used for determination of the surface area of the different
compartments. D. Relationship between TCA-computed and measured fractional volumes of the 4 compartments in 8 samples analyzed as described
in C (same color code as in C). The slope of the regression line was not statistically different from 1 (t test).
doi:10.1371/journal.pone.0007779.g002
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whereas the effect will be maximal for a gene expressed in a single
compartment.
As demonstrated by examples illustrated in figure 6, the wide
structural diversity of samples can be utilized to select sub-groups
of samples with different enrichment in a given structure, and
thereby to identify gene expression profile along the nephron.
Interestingly, this approach can be developed at a single kidney
level, since multiple sampling of a same kidney yields the same
diversity as sampling from different kidneys (Fig. 3C).
Since the easy-to-use TCA method proved to be efficient in
overcoming the kidney high heterogeneity, it could be applied
successfully to any heterogeneous tissue inasmuch structure
specific markers with defined expression levels are available. For
example, TCA could be applied to central nervous system where
tissue heterogeneity is a limiting factor [18], and specific structure
markers are defined [19]. Choice of putative markers can be
orientated by functional knowledge on tissues, and their
quantification can be obtained indifferently by either RT-PCR
or SAGE or microarray.
For application to kidney tissue, potential users should quantify
by RT-qPCR their gene(s) of interest along with the 8 structure
markers here proposed and the general marker RPLP1. In
addition, they should look for gene specific tag abundance in
Figure 3. Structural heterogeneity of samples. TCA-computed
fractional volumes of proximal convoluted tubules (PCT, blue),
glomeruli (G, yellow), cortical thick ascending limbs of Henle’s loop
(cTAL, green) and aldosterone-sensitive distal nephron (CCD, red) in 94
normal samples (A), 36 pathological needle biopsies (B) and twenty
fragments of normal tissue from a same patient (C). Samples are ranged
according to increasing fractional volume of PCTs.
doi:10.1371/journal.pone.0007779.g003
Figure 4. Data standardization. Expression of NPHS2 (podocin),
GSTA1 (Glutathione S-transferase a1), DUSP9 (Dual-specificity phospha-
tase 9), PTGER1 (Prostaglandin E receptor 1), KCNJ1 (Renal outer
medullary potassium channel, ROMK1) and MUC1 (Mucin 1) in 60
normal samples was standardized either by the reference gene RPLP1
(blue points) or by SF (pink points). Similar results were obtained when
using RPL19 or PPIA as reference genes. Data are expressed as fold
of the lowest value, and samples are ranged according to increasing
SF-standardized values. Values in the graphs are the variances for
RPL1-normalized (blue) and SF-normalized data (pink).
doi:10.1371/journal.pone.0007779.g004
Figure 5. Identification of pathology markers. Expression of
COL4A5 (collagen type IV, alpha-5), DCN (decorin), SERPINH1 (serpin
peptidase inhibitor, H1), CTGF (connective tissue growth factor) and
TRPC6 (transient receptor potential cation channel C6) in normal tissue
(open columns C, n=64) and pathological biopsies (hatched columns):
DN, diabetic nephropathy (n=7); MN, membranous nephropathy
(n=7); IgAN, IgA nephropathy (n=5); LN, lupus nephropathy (n=7).
Data were standardized using either the reference gene RPLP1 (left,
open columns) or SF (right, grey columns), and results are expressed as
percent 6 SE of normal group. Statistical comparisons with normal
groups were performed by one way ANOVA followed by Holm-Sidak
test: *, p,0.01; **, p,0.005; ***, p,0.001.
doi:10.1371/journal.pone.0007779.g005
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calculate Vs and SFs as indicated above and normalize data.
For application to other heterogeneous tissues, potential users will
first have to identify and validate couples of compartment-specific
markers. For this purpose, the three criteria selected above (high
expression level, responsible for compartment-specific function,
and low inter-individual differences) might be helpful.
TCA is primarily well suited for human studies, because the
small size of tissue samples collected in clinical practice is
associated with high structural diversity. Its two main domains
of application are: a) the follow up of identified biomarkers in
tissue biopsies from single patients for diagnosis and/or prognosis
as well as for evaluation of therapy efficiency, and b) the
identification of new pathological markers through large scale
analysis of tissue libraries. For this later application, it is worth
pointing out that a posteriori analysis of existing data might be
possible since specific probes or tags for structure markers are
likely present on commercially available microarrays or in SAGE
databases, respectively. TCA method may also be of interest in
experimental studies for longitudinal follow up of single animals by
repeated tissue biopsies. Spreading out TCA method to data
analysis is expected to boost the outcomes of high throughput gene
expression studies, especially to reveal otherwise imperceptible
gene expression changes and for discovery of molecular markers of
diseases.
Methods
Human Kidney Samples
Normal kidney tissue samples were obtained from 94 patients
who had undergone surgery at the Department of Urology (North
Hospital, CHU of Saint-Etienne, France) for kidney tumors.
Written informed patient consent was obtained for studying
gene expression profiles, and the study protocol was approved
by the ‘‘Comite ´ Consultatif de Protection des Personnes dans
la Recherche Biome ´dicale Rho ˆne-Alpes Loire’’, France. After
surgery, a kidney fragment taken at distance from the tumor, and
later characterized as normal on histological basis, were snap-
frozen with liquid nitrogen and stored at 280uC until studies. At
the time of study, tissue samples were broken into smaller
fragments in a mortar cooled in liquid nitrogen, and individual
fragments were processed directly for RNA extraction.
Pathological kidney tissue was from the bio-library established
by the Nephrology department at European Georges Pompidou
Hospital (Paris, France), where needle biopsies are routinely
collected at nephropathy diagnosis or during the follow up of the
kidney disease. We retrospectively randomly selected 41 patients
whose nephropathy was minimal change disease (n=21),
idiopathic membranous nephropathy (n=7), diabetic glomerulo-
sclerosis (n=7), systemic erythematous lupus nephritis (n=7), IgA
nephropathy (n=5), and renal sarcoidosis (n=3).
Preparation of Serial Tissue Sections
Frozen normal kidney tissue samples from two patients were
stuck on tissue holders with tissue freezing medium. Three 8-mm
serial frozen sections were cut on a standard cryostat with a clean
blade. Two sections used for immunostaining were mounted on
poly-L–lysine-precoated glass slides (Menzel-glaser, Germany),
and successively dried at room temperature for 15 min, fixed for
2 min in ice-cold acetone, dried for 15 min, and rapidly washed
with 1X phosphate-buffered saline (PBS), pH 7.4, before staining.
The 3
rd tissue section was used for laser capture microdissection
(LCM) and RNA extraction. It was mounted on a slide coated with
a thermoplastic membrane (PEN foil slides; Leica Microsystems,
Wetzlar, Germany) and successively fixed with 70% ethanol at
220uC for 1 min to minimize nucleic acid degradation,
thoroughly air dried, and stained for 45 sec at room temperature
with a modified toluidine blue staining procedure. Thereafter, it
was rapidly rinsed with xylene, and air dried before LCM. From
each toluidine blue-stained section, four rectangular regions of
approximately 161.4 mm were dissected with a Leica SVS LMD
Figure 6. Localization of gene expression. Determination of the
composition of kidney samples may serve to localize gene expression
along the nephron through comparison of expression levels in subgroups
ofsampleswithdifferentenrichmentinagivenstructure.Thisisillustrated
for DUSP9 (Dual-specificity phosphatase 9), MUC1 (Mucin 1), GSTA1
(Glutathione S-transferase a1) and DCN (decorin), by comparing (A)e i g h t
subgroups made of the ten samples with the lowest (hatched columns)
and the highest (full columns) proportions of G (yellow), PCT (blue), cTAL
(green) and CCD (red), (B) subgroups with similar cTAL content but
different CCD content (groups 1 (n=5) and 2 (n=5)) or with similar CCD
content but different cTAL content (groups 2 and 3 (n=5)), and (C)
subgroups with similar G content but different PCT content (groups
1(n=6) and 2 (n=4)) or with similar PCT content but different G content
(groups 2 and 3 (n=8)). Results indicate that A: DUSP9 and MUC1 were
preferentially expressed in cTAL- and CCD-rich samples whereas GSTA1
and DCN were preferentially expressed in G- and PCT-rich samples.
Statistical differences between groups: *, p,0.05; **, p,0.001; B:D U S P 9
was preferentially expressed in cTAL whereas MUC1 was expressed in
both cTAL and CCD because DUSP9 expression increased with cTAL
content but not with CCD content, whereas MUC1 expression increased
with both cTAL and CCD contents. Statistical comparison was performed
between groups 1 and 2 and groups 2 and 3: *, p,0.01; **p,0.005; and
C: GSTA1 and DCN were preferentially expressed in PCT and G
respectively. Statistical comparison was performed between groups 1
and 2 and groups 2 and 3: **p,0.005. These conclusions are consistent
with known expression profiles of these four genes (table 1).
doi:10.1371/journal.pone.0007779.g006
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before and after LCM. Individual LCM-derived pieces of tissue
were collected by gravity into a microcentrifuge tube containing
65 ml RLT buffer of the RNeasy Micro Kit from Qiagen
complemented with b-mercaptoethanol for immediate RNA
extraction.
Immunostaining
The two remaining serial sections were used for immunostain-
ing cTAL and CCD respectively. For CCD, acetone-fixed sections
were incubated for 30 min at room temperature with the murine
monoclonal anti-AQP2 antibody 1321 (1:1000 dilution, Santa
Cruz Biotechnology), rinsed thrice with PBS, and incubated with
TRITC-conjugated goat anti-mouse immunoglobulin (1:100
dilution, Sigma) for 30 min at room temperature. For cTAL
staining, acetone-fixed sections were incubated with a human anti-
uromucoid goat antibody (1:200 dilution, Cappel) for 30 min at
room temperature, rinsed thrice in PBS, and incubated with
FITC-conjugated goat anti-rabbit immunoglobulin (1:50 dilution;
Dako Cytomation) for 30 min at room temperature. Before
mounting for microscopic observation, slides were rinsed twice for
5 min in PBS.
Histo-Morphometric Analysis of Serial Tissue Sections
Comparison of the micrographs of toluidine blue-stained
sections, before and after LCM, with cognate immuno-stained
sections allowed localizing the dissected zones on the three stained
sections (Fig. 2A), and their histological composition was analyzed
using Photoshop (Adobe Photoshop 6.0). After delineating cTALs
and CCDs on the corresponding immuno-stained micrographs, Gs
and PCTs were characterized on morphological basis on toluidine
blue-stained sections (Fig. 2B) and delineated. Based on this
histological analysis, a five color-coded image of each LCM-
derived zone was constructed (Fig. 2C), and the overall surface
area of each of the four structures of interest (G, PCT, cTAL and
CCD) was determined (in pixels), expressed as percent of the sum
of the four structures, and compared with data from TCA method
(Fig. 2D). Note that this analysis does not take into account the
fifth compartment (in grey in Fig. 2C) consisting in other nephron
segments (mainly distal convoluted tubule), vascular structures and
interstitial tissue. Histological and morphometric analysis of each
LCM-derived zone was performed by two independent investiga-
tors and results are mean values of the two observations.
RNA Extraction
RNAs from LCM-derived tissue pieces were immediately
extracted using RNeasy Micro kit (Qiagen) according to the
manufacturer’s protocol for isolation of nucleic acids from
microdissected cryosections. After DNase digestion (RNase-free
DNase, Qiagen), the total RNA was washed and eluted with 14 ml
of RNase-free water.
RNAs were also extracted from 10–20 mg frozen fragments of
normal tissue and from entire biopsies of pathological tissue
(2–3 mg), using RNeasy Mini and Micro Kit (Qiagen), respec-
tively. Briefly, tissue fragments were homogenized with 350 mlo f
RLT complemented with b-mercaptoethanol in a spin/rotation
instrument (FastPrep-120; Q BIOgene, 45 sec, speed 6). After
centrifugation (10,000 g, 3 min at room temperature), the cell
lysate (supernatant) was transferred onto spin-column (Qiagen)
and treated according to the manufacturer’s instructions for
isolation of nucleic acids from animal tissues. After DNase
digestion (RNase-free DNase, Qiagen), the total RNA was washed
and eluted with RNase-free water (45 and 15 ml for normal and
pathological tissue respectively).
RNA samples quality was checked on a Bioanalyzer 2100
System (Agilent Technologies, Palo Alto, CA, USA) and their
concentration was confirmed by measuring their OD at 260 nm
before reverse transcription.
Reverse Transcription and Quantitative Real-Time
Polymerase Chain Reaction (qPCR)
Reverse transcription was carried out in a final volume of 20 ml
containing 10 U M-MLV reverse transcriptase (Roche), 1 mmol/l
dNTPs (Eurobio, France), 20 U RNase inhibitor (Roche),
60 pmol/ml random hexamers (Roche) and approximately
200 ng RNA. Reverse transcription was carried out for 60 min
at 42uC, followed by 5 min at 95uC and 5 min at 4uC.
PCR was carried out in 96-well plates using a LightCyclerH 480
system (Roche Dagnostics). The reaction mixture contained 5 mlo f
LightCyclerH 480 SYBR Green I Master mix (Roche Diagnostics),
0.5 ml of sense and antisense primers (0.5 mM final concentration)
and 4 ml of reverse transcription product that was diluted so as to
add a cDNA amount corresponding to 0.4 ng reverse-transcribed
RNA. The reaction protocol included: 5 min at 95uC, followed by
45 cycles consisting of 10 sec at 95uC, 20 sec at 60uC and 20 sec at
72uC, and terminated with a melting curve analysis (from 60uCt o
95uC) to check the specificity of the PCR product. Specific primers
(Table 2) were designed using the Light Cycler probe design
software.
The initial number of cDNA copies (W) was calculated as:
W ~ K=L | Eff Cp
Table 2. Sequence of nucleotide primers used for PCR.
Gene Sense Antisense
ALDOB 59- gaggattgccgaccag-39 59- ggtcattcagggcctt-39
AQP2 59- cacgcattactagaatcattt-39 59- ggttcaaggtatgaccca-39
SERPINH1 59-ggtaccagccttggatact-39 59- gggcaggcagaatgacta-39
COL4A5 59- ggccctcacattcctccta-39 59- cctgaaataccagttccaatgc-39
CTGF 59- ctagagaagcagagccgc-39 59- agaatttagctcggtatgtcttca-39
DCN 59- caacacgcctcatctg-39 59- aagactcacacccgaata-39
DUSP9 59-gcatccgctacatcct-39 59-cagtgacggtgacaga-39
FXYD4 59- gccaataaagacgatccc-39 59- gggcgagtttaattcataaag-39
GSTA1 59- atcgctacttccctgc-39 59- tgactgcgttattaaaacct-39
KCNJ1 59- gtggtatgcagtagcg-39 59- agccactcggattagg-39
MUC1 59-gtcagcgtgagtgatgt-39 59-gtactcgctcataggatgg-39
NPHS2 59- atttgctaccgaatgg-39 59- gcaatcatccgcactt-39
PODXL 59- agaattgctactcgaagg-39 59- gctagtgaccgtgaca-39
PPIA 59-gcatacgggtcctggcatctt-39 59-acatgcttgccatccaaccac-39
PTGER1 59- gtcggtatcatggtggtgtc-39 59- ggatgtacacccaagggttc-39
RPLP1 59- cacggaggataagatcaat-39 59- gcccatgtcatcatcaga-39
RPL19 59-tgctcacaagataccgtg-39 59-agacaaagtgggaggtt-39
SLC13A3 59- gctgacatctcgaccc-39 59-aacatgcttaccacttaagg-39
SLC12A1 59- ggagacctgcgtatgg-39 59- tggtaaaggcgtgagt-39
TRPC6 59- catattcattatggtgtttgtggc-39 59- ctgatttcacttcagaaagtccaaatatag-39
UMOD 59- ccagaccccttcctac-39 59- cagcaaaccggaacat-39
WT1 59- ccaggccaggatgtttcctaa-39 59ctcatgcttgaatgagtggttg-39
Specific primers were designed using the Light Cycler Probe Design software.
Gene symbols are from HUGO.
doi:10.1371/journal.pone.0007779.t002
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PCR efficiency and Cp is the number of PCR cycles where the
reaction fluorescence reaches its second derivative maximum
(threshold of fluorescence detection). Because K is unknown, this
method does not allow the absolute quantification of a given
transcript, but it permits calculating the relative abundance of two
transcripts W1/W2.
Eff was determined using a standard curve made from 10-fold
serial dilutions of a standard cDNA stock solution made from a
mixture of 10 samples, and Cp was calculated by the LightCyclerH
480 software. For each couple of primers, PCR was done twice for
samples and four times for the standard curve, and mean Eff and
Cp values were taken for calculations. Because Eff is raised to the
Cp
th power, its determination must be as accurate as possible.
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